Name of Issuer:
Cardlytics, Inc. (the Issuer)
Address of Issuers Principal Executive Offices:
675 Ponce de Leon Avenue NE, Ste 6000, Atlanta GA 30308
Name of Person Filing:
This Schedule 13G is being filed on behalf of each of Aeroplan Holdings Europe Sàrl and its parent corporation, Aimia Inc. (together, the
Address of Principal Business Office or, if none, Residence:
The address for each of the Reporting Persons is:
c/o Aimia Inc.
525 Viger Avenue
West, Suite 1000, Montreal, QC Canada H2Z 0B2
Aeroplan Holdings Europe Sàrl is a company under the laws of Luxembourg.
Aimia Inc. is a corporation under the laws of Canada.
Title of Class of Securities:
Common stock, par value $0.0001 per share.
If This Statement Is Filed Pursuant to Sections 240.13d-1(b) or 240.13d-2(b) or (c), Check Whether the Person Filing Is a(n): N/A
Based on 24,327,687 shares of common stock outstanding as of September 13, 2019 reported by the Issuer in its Prospectus Supplement, dated
September 10, 2019, filed pursuant to the Registration Statement on Form S-3 (Registration No. 333-232861), filed with the Securities and Exchange Commission
on September 10, 2019.
Amount beneficially owned:
See Row 9 of cover page.
See Row 11 of cover page.
Number of shares as to which the person has:
Sole power to vote or to direct the vote:
See Row 5 of cover page.